| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CHGA | INS-IGF2 | ENSPPYP00000006915 | ENSPPYP00000003393 | CHGA isoform 1. | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.618 |
| CHGA | PAM | ENSPPYP00000006915 | ENSPPYP00000017516 | CHGA isoform 1. | Peptidylglycine alpha-amidating monooxygenase. | 0.494 |
| CHGA | SCG5 | ENSPPYP00000006915 | ENSPPYP00000007139 | CHGA isoform 1. | Secretogranin V. | 0.571 |
| CPE | INS-IGF2 | ENSPPYP00000016961 | ENSPPYP00000003393 | Carboxypeptidase E. | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.645 |
| CPE | PAM | ENSPPYP00000016961 | ENSPPYP00000017516 | Carboxypeptidase E. | Peptidylglycine alpha-amidating monooxygenase. | 0.543 |
| CYB561 | PAM | ENSPPYP00000009572 | ENSPPYP00000017516 | Cytochrome b561; Secretory vesicle-specific electron transport protein. | Peptidylglycine alpha-amidating monooxygenase. | 0.594 |
| INS-IGF2 | CHGA | ENSPPYP00000003393 | ENSPPYP00000006915 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | CHGA isoform 1. | 0.618 |
| INS-IGF2 | CPE | ENSPPYP00000003393 | ENSPPYP00000016961 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Carboxypeptidase E. | 0.645 |
| INS-IGF2 | PAM | ENSPPYP00000003393 | ENSPPYP00000017516 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Peptidylglycine alpha-amidating monooxygenase. | 0.510 |
| NEFL | PAM | ENSPPYP00000020675 | ENSPPYP00000017516 | Neurofilament light polypeptide; Neurofilaments usually contain three intermediate filament proteins: L, M, and H which are involved in the maintenance of neuronal caliber. | Peptidylglycine alpha-amidating monooxygenase. | 0.528 |
| PAM | CHGA | ENSPPYP00000017516 | ENSPPYP00000006915 | Peptidylglycine alpha-amidating monooxygenase. | CHGA isoform 1. | 0.494 |
| PAM | CPE | ENSPPYP00000017516 | ENSPPYP00000016961 | Peptidylglycine alpha-amidating monooxygenase. | Carboxypeptidase E. | 0.543 |
| PAM | CYB561 | ENSPPYP00000017516 | ENSPPYP00000009572 | Peptidylglycine alpha-amidating monooxygenase. | Cytochrome b561; Secretory vesicle-specific electron transport protein. | 0.594 |
| PAM | INS-IGF2 | ENSPPYP00000017516 | ENSPPYP00000003393 | Peptidylglycine alpha-amidating monooxygenase. | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.510 |
| PAM | NEFL | ENSPPYP00000017516 | ENSPPYP00000020675 | Peptidylglycine alpha-amidating monooxygenase. | Neurofilament light polypeptide; Neurofilaments usually contain three intermediate filament proteins: L, M, and H which are involved in the maintenance of neuronal caliber. | 0.528 |
| PAM | RASSF10 | ENSPPYP00000017516 | ENSPPYP00000003990 | Peptidylglycine alpha-amidating monooxygenase. | RASSF10 isoform 1. | 0.761 |
| PAM | RHOG | ENSPPYP00000017516 | ENSPPYP00000004149 | Peptidylglycine alpha-amidating monooxygenase. | Ras homolog family member G. | 0.520 |
| PAM | SCG5 | ENSPPYP00000017516 | ENSPPYP00000007139 | Peptidylglycine alpha-amidating monooxygenase. | Secretogranin V. | 0.528 |
| PAM | TOR2A | ENSPPYP00000017516 | ENSPPYP00000021996 | Peptidylglycine alpha-amidating monooxygenase. | Torsin. | 0.570 |
| PAM | UHMK1 | ENSPPYP00000017516 | ENSPPYP00000000680 | Peptidylglycine alpha-amidating monooxygenase. | Serine/threonine-protein kinase Kist; Upon serum stimulation, phosphorylates CDKN1B/p27Kip1, thus controlling CDKN1B subcellular location and cell cycle progression in G1 phase. May be involved in trafficking and/or processing of RNA (By similarity). | 0.615 |
